<?xml version="1.0" encoding="UTF-8"?>
<p>Vero cells (CCL-81, ATCC, Manassas, VA, USA), A549-Dual™ cells (a549d-nfis, InvivoGen, San Diego, CA, USA) and human embryonic kidney HEK-293 cells (CRL-1573, ATCC, Manassas, VA, USA) were cultured at 37 °C under a 5% CO
 <sub>2</sub> atmosphere in MEM medium, supplemented with 5% to 10% heat-inactivated foetal bovine serum (FBS). A549-Dual™ (A549
 <sup>DUAL</sup>) cells were maintained in growth medium supplemented with nonessential amino acids, 10 µg·mL
 <sup>−1</sup> blasticidin and 100 µg·mL
 <sup>−1</sup> zeocin (InvivoGen, San Diego, CA, USA). Chloroquine phosphate was purchased from Sigma-Aldrich (Saint-Louis, MO, USA). Rat antibody specifically raised against ZIKV E protein Domain III was developed 
 <italic>in-house</italic> and used in immunoblot with reducing conditions [
 <xref rid="B28-cells-08-01444" ref-type="bibr">28</xref>]. Mouse anti-pan flavivirus envelope E protein monoclonal antibody (mAb) 4G2 was purchased from RD Biotech (Besancon, France) and used in immunoblot with nonreducing conditions. Horseradish peroxidase-conjugated anti-rabbit and anti-mouse antibodies were purchased from Vector Laboratories (Burlingame, CA, USA).
</p>
